Sanofi India Ltd. Stock price: Live updates

₹3451.3

1.32% (45.0)

Market Cap

₹7,845 Cr.

P/E

25.32

Key Ratios

Edit Ratio's

Market cap

7,845 Cr

25.32

Prom Holding

60.40 %

ROE (%)

43.61

ROCE (%)

24.82

Div Yield (%)

3.61

Sales

1,773 Cr

OPM (%)

26.06 %

Debt to Equity

Institutions

26.77 %

Individual < 2 lac

9.87 %

No. of Shareholders

75,758

Edit Ratio's

About

Sanofi India Limited is a pharmaceutical company with a manufacturing facility in Goa and mult… Read more

Low

3054

52W Range

High

6372

Timeline

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statement

Edit rows

Forensics

11 Yes

Positive for this company

2 Neutral

Neutral for this company

4 No

Negative for this company

0 No Data

Insufficient data to analyse

Accounting & Shareholding

Contingent Liabilities

Company does not have significant contingent liabilities
Depreciation Effect

Depreciation accounting is not leading to increase in profits
Other Income

Other income is not affecting ratios of the company
Pledge

Promoters have not pledged a significant portion of their holding
Promoter Holding

Promoter has not sold any shares in the last 90 days
Retail Holding

Retail has been buying the stock which is usually a sign of exuberance
Revenue Recognition

Chances of aggressive revenue recognition - operating profit of company is not getting converted to cash and recievables rising faster than sales

Price & Performance

Capex vs ROCE

Roce of the company has increased over the last three years
ROE

Net profit margin is responsible for roe increase over last 10 years
Share price

Share price has increased over last 10 years due to earnings
Working Capital

Working capital of the company seems to be under control
Current vs Historic Valuation

Company is trading at a discount to 3yr historic valuations
Debt

Company should not have issues servicing its debt
ROCE Strength

Roce of the company is consistently strong
Balance Sheet Strength

Balance sheet of the company is moderately strong
Sales Growth

Sales of the company has grown at a slow pace
Margin Stability

Margins of the company are volatile

Market Share

6.24 %

(as of Jul 22)

Historic

Anti - Diabetes - Market Share

0.32 %

(as of Jul 22)

Historic

Anti-Infectives - Market Share

0.05 %

(as of Mar 19)

Historic

Antineo Plastic - Market Share

1.97 %

(as of Jul 22)

Historic

Cardiovascular - Market Share

0.55 %

(as of Mar 19)

Historic

Dermatology - Market Share

1.80 %

(as of Jul 22)

Historic

Gastro-Intestinal - Market Share

2.67 %

(as of Mar 19)

Historic

Neurological - Market Share

2.87 %

(as of Mar 19)

Historic

Pain - Market Share

1.60 %

(as of Dec 22)

Historic

Pharmaceutical Sector - Market Share

3.38 %

(as of Mar 19)

Historic

Respiratory - Market Share

0.10 %

(as of Mar 19)

Historic

Sex Stimulants - Market Share

20.16 %

(as of Jul 22)

Historic

Vaccines - Market Share

0.12 %

(as of Jul 22)

Historic

Vitamin & Dietary Supplements - Market Share

Revenue mix

Product Wise Break-Up

Therapeutic Area Wise Break-Up - Domestic

Location Wise Break-Up

Operational Metrics

Domestic Sales Growth - YoY (%)
Source
R&D as a % of Total Sales (%)
Source

Peer Comparison

Brands

Allegra

Avil

Combiflam

Corporate Actions

Consolidated

DATE

DETAILS

Show Less

Suppliers

Aarti Industries Ltd.
Shaily Engineering Plastics Ltd.
Bliss GVS Pharma Ltd.
IOL Chemicals And Pharmaceuticals Ltd.
Aarti Drugs Ltd.
HLE Glascoat Ltd.
Vidhi Specialty Food Ingredients Ltd.
NIIT Ltd.
Take Ltd.
Wintac Ltd.

Showing 5 of 10

FAQs on Sanofi India Ltd. Business

What does Sanofi India do?

Sanofi India Limited sells a wide range of medications and dietary supplements for the treatment of various diseases in India. The company primarily operates through independent distributors.

Who are the competitors of Sanofi India?

Sanofi India major competitors are FDC, Bliss GVS Pharma, Strides Pharma Scien, Procter&Gamble Healt, Orchid Pharma, Zota Health Care, Guj. Themis Biosyn.
Market Cap of Sanofi India is ₹7,764 Crs.
While the median market cap of its peers are ₹5,643 Crs.

Is Sanofi India financially stable compared to its competitors?

Sanofi India seems to be less financially stable compared to its competitors.
Altman Z score of Sanofi India is 2.31 and is ranked 8 out of its 8 competitors.

View FAQ's On Shareprice

Company Filing

	2026	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY26	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release			Jun Sep
Investor Presentation	Feb	Oct	Mar	Mar Sep Dec	Dec		Dec
Conference Call	Mar	Nov	Mar	Mar Sep Dec	Dec
Conference Call SummaryCon Call Summary Powered by Claude

Discussions & Analysis

Sanofi India Ltd.

View the discussion on ValuePickr

Ideas Dashboard

Results

Timeline

Watchlist

Portfolio

Alerts

Stock Screener

Market

Raw Material

Sanofi India Ltd.

Sanofi India Ltd.

Key Ratios

About

Timeline

Company Timeline

Custom financial statement

Forensics

11 Yes

2 Neutral

4 No

0 No Data

Accounting & Shareholding

Contingent Liabilities

Depreciation Effect

Other Income

Pledge

Promoter Holding

Retail Holding

Revenue Recognition

Price & Performance

Capex vs ROCE

ROE

Share price

Working Capital

Current vs Historic Valuation

Debt

ROCE Strength

Balance Sheet Strength

Sales Growth

Margin Stability

Market Share

Revenue mix

Product Wise Break-Up

UNLOCK PREMIUM

Therapeutic Area Wise Break-Up - Domestic

UNLOCK PREMIUM

Location Wise Break-Up

UNLOCK PREMIUM

Operational Metrics

Peer Comparison

Brands

Corporate Actions

Suppliers

FAQs on Sanofi India Ltd. Business

What does Sanofi India do?

Who are the competitors of Sanofi India?

Is Sanofi India financially stable compared to its competitors?

Company Filing

Discussions & Analysis

SIGN UP FOR FREE